Literature DB >> 23973800

Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions.

Ying Wang1, Bin-Kuan Chou, Sarah Dowey, Chaoxia He, Sharon Gerecht, Linzhao Cheng.   

Abstract

Large-scale production of human induced pluripotent stem cells (hiPSCs) by robust and economic methods has been one of the major challenges for translational realization of hiPSC technology. Here we demonstrate a scalable culture system for hiPSC expansion using the E8 chemically defined and xeno-free medium under either adherent or suspension conditions. To optimize suspension conditions guided by a computational simulation, we developed a method to efficiently expand hiPSCs as undifferentiated aggregates in spinner flasks. Serial passaging of two different hiPSC lines in the spinner flasks using the E8 medium preserved their normal karyotype and expression of undifferentiated state markers of TRA-1-60, SSEA4, OCT4, and NANOG. The hiPSCs cultured in spinner flasks for more than 10 passages not only could be remained pluripotent as indicated by in vitro and in vivo assays, but also could be efficiently induced toward mesodermal and hematopoietic differentiation. Furthermore, we established a xeno-free protocol of single-cell cryopreservation and recovery for the scalable production of hiPSCs in spinner flasks. This system is the first to enable an efficient scale-up bioprocess in completely xeno-free condition for the expansion and cryopreservation of hiPSCs with the quantity and quality compliant for clinical applications.
© 2013.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23973800      PMCID: PMC4628790          DOI: 10.1016/j.scr.2013.07.011

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  44 in total

1.  Location of scaffolds in bioreactors modulates the hydrodynamic environment experienced by engineered tissues.

Authors:  Bahar Bilgen; Gilda A Barabino
Journal:  Biotechnol Bioeng       Date:  2007-09-01       Impact factor: 4.530

2.  ROCK inhibitor improves survival of cryopreserved serum/feeder-free single human embryonic stem cells.

Authors:  Xiangyun Li; Roman Krawetz; Shiying Liu; Guoliang Meng; Derrick E Rancourt
Journal:  Hum Reprod       Date:  2008-12-04       Impact factor: 6.918

3.  Adapting human pluripotent stem cells to high-throughput and high-content screening.

Authors:  Sabrina C Desbordes; Lorenz Studer
Journal:  Nat Protoc       Date:  2012-12-20       Impact factor: 13.491

4.  Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products.

Authors:  Yan Li; Sandra Powell; Elisa Brunette; Jane Lebkowski; Ramkumar Mandalam
Journal:  Biotechnol Bioeng       Date:  2005-09-20       Impact factor: 4.530

5.  Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells.

Authors:  Michal Amit; Ilana Laevsky; Yael Miropolsky; Kohava Shariki; Meital Peri; Joseph Itskovitz-Eldor
Journal:  Nat Protoc       Date:  2011-04-07       Impact factor: 13.491

6.  Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions.

Authors:  Jeanette Beers; Daniel R Gulbranson; Nicole George; Lauren I Siniscalchi; Jeffrey Jones; James A Thomson; Guokai Chen
Journal:  Nat Protoc       Date:  2012-10-25       Impact factor: 13.491

7.  A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies.

Authors:  Elizabeth S Ng; Richard Davis; Edouard G Stanley; Andrew G Elefanty
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

8.  Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation.

Authors:  Jayesh Mehta; Jayesh Mehta; Olga Frankfurt; Jessica Altman; Andrew Evens; Martin Tallman; Leo Gordon; Stephanie Williams; Jane Winter; Jairam Krishnamurthy; Sara Duffey; Veerpal Singh; Richard Meagher; David Grinblatt; Lynne Kaminer; Seema Singhal
Journal:  Leuk Lymphoma       Date:  2009-09

9.  Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.

Authors:  Bin-Kuan Chou; Prashant Mali; Xiaosong Huang; Zhaohui Ye; Sarah N Dowey; Linda Ms Resar; Chunlin Zou; Y Alex Zhang; Jay Tong; Linzhao Cheng
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

10.  Derivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures.

Authors:  David A Fluri; Peter D Tonge; Hannah Song; Ricardo P Baptista; Nika Shakiba; Shreya Shukla; Geoffrey Clarke; Andras Nagy; Peter W Zandstra
Journal:  Nat Methods       Date:  2012-03-25       Impact factor: 28.547

View more
  48 in total

1.  Cardiac differentiation of human pluripotent stem cells in scalable suspension culture.

Authors:  Henning Kempf; Christina Kropp; Ruth Olmer; Ulrich Martin; Robert Zweigerdt
Journal:  Nat Protoc       Date:  2015-08-13       Impact factor: 13.491

Review 2.  Concise review: stem cell-based approaches to red blood cell production for transfusion.

Authors:  Siddharth Shah; Xiaosong Huang; Linzhao Cheng
Journal:  Stem Cells Transl Med       Date:  2013-12-20       Impact factor: 6.940

Review 3.  Dendritic cells derived from pluripotent stem cells: Potential of large scale production.

Authors:  Yan Li; Meimei Liu; Shang-Tian Yang
Journal:  World J Stem Cells       Date:  2014-01-26       Impact factor: 5.326

4.  Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System.

Authors:  Michael K Conway; Michael J Gerger; Erin E Balay; Rachel O'Connell; Seth Hanson; Neil J Daily; Tetsuro Wakatsuki
Journal:  J Vis Exp       Date:  2015-05-14       Impact factor: 1.355

Review 5.  Induced pluripotent stem cells for regenerative medicine.

Authors:  Karen K Hirschi; Song Li; Krishnendu Roy
Journal:  Annu Rev Biomed Eng       Date:  2014-05-29       Impact factor: 9.590

6.  Retinoic acid (RA) and bone morphogenetic protein 4 (BMP4) restore the germline competence of in vitro cultured chicken blastodermal cells.

Authors:  Xiaochuan Tang; Jun Shi; Xiaolian Qin; Ning Xiao; Rongyang Li; Hao Hu; Fengshuo Yang; Deshun Shi; Xiaoli Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-02-08       Impact factor: 2.416

7.  Definitive Hematopoietic Multipotent Progenitor Cells Are Transiently Generated From Hemogenic Endothelial Cells in Human Pluripotent Stem Cells.

Authors:  Hao Bai; Yanfeng Liu; Yinliang Xie; Dixie L Hoyle; Robert A Brodsky; Linzhao Cheng; Tao Cheng; Zack Z Wang
Journal:  J Cell Physiol       Date:  2015-10-14       Impact factor: 6.384

8.  A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.

Authors:  Bin-Kuan Chou; Haihui Gu; Yongxing Gao; Sarah N Dowey; Ying Wang; Jun Shi; Yanxin Li; Zhaohui Ye; Tao Cheng; Linzhao Cheng
Journal:  Stem Cells Transl Med       Date:  2015-03-05       Impact factor: 6.940

Review 9.  Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.

Authors:  Angelos Oikonomopoulos; Tomoya Kitani; Joseph C Wu
Journal:  Mol Ther       Date:  2018-03-06       Impact factor: 11.454

Review 10.  Small molecule screening in human induced pluripotent stem cell-derived terminal cell types.

Authors:  Sandra J Engle; Fabien Vincent
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.